"It's a big added stress on top of being so ill": The challenges facing people prescribed cannabis in the UK

被引:5
作者
Beckett Wilson, Helen [1 ]
Metcalf McGrath, Lindsey [1 ]
机构
[1] Liverpool John Moores Univ, Liverpool, England
关键词
Medical cannabis; Drug policy; Social harm; Health inequality; Prohibition; Stigma; MEDICAL CANNABIS; HARMS;
D O I
10.1016/j.drugpo.2023.104220
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: This paper reports on the first qualitative study to interview people prescribed cannabis in the UK. Cannabis is a class B controlled substance under the 1971 Misuse of Drugs (MoD) Act, but a 2018 change to UK regulations provided for the prescription of cannabis for medical purposes. Relatively few people have been able to access a prescription, despite this policy change. This paper examines their experiences.Methods: Qualitative, semi-structured interviews were conducted with 24 people with a prescription for cannabis, or their carers. Data was analysed using a reflextive thematic analysis approach. The findings are discussed using a zemiology (social harms) perspective which provides a language for critical reflection on the current cannabis policy context.Results: All participants reported that cannabis had significantly improved their mental and/or physical health, across a broad range of conditions. Many had been able to reduce their use of conventional medicines and reported that cannabis had relatively few side effects. Despite the potentially life-enhancing benefits of cannabis medicine, patients in the UK face multiple barriers to access. These include a lack of funding streams, bureaucratic supply problems, and a lack of training for doctors and police. Even for the few people able to obtain a prescription, the ongoing criminalisation of cannabis in the UK contributed to their experiences of stigmatisation. This often made it difficult and anxiety-inducing to take their medicine in public spaces.Conclusion: The UK government's lack of implementation of medical cannabis legalisation, combined with their ongoing prohibition position, is producing multiple harms to people who need cannabis medicine. The policy context is perpetuating stigmatising attitudes to cannabis which, as we demonstrate, contribute to social harms. We make recommendations on equality of patient access, and highlight the importance of education and policy change as means of combatting stigma.
引用
收藏
页数:9
相关论文
共 54 条
[1]  
ACMD (Advisory Council on the Misuse of Drugs), 2020, CANN BAS PROD MED US
[2]  
[Anonymous], 2018, MISUSE DRUGS AMENDME
[3]  
[Anonymous], 1971, MISUSE DRUGS ACT
[4]   Real World Evidence in Medical Cannabis Research [J].
Banerjee, Rishi ;
Erridge, Simon ;
Salazar, Oliver ;
Mangal, Nagina ;
Couch, Daniel ;
Pacchetti, Barbara ;
Sodergren, Mikael Hans .
THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2022, 56 (01) :8-14
[5]   ESSAY The case for medical cannabis-an essay by M P Barnes [J].
Barnes, M. P. .
BMJ-BRITISH MEDICAL JOURNAL, 2018, 362
[6]  
Barnes M P., 2016, Cannabis: The Evidence for Medical Use. Em
[7]   Older adults experiences of using recreational cannabis for medicinal purposes following legalization [J].
Baumbusch, Jennifer ;
Yip, Isabel Sloan .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2022, 108
[8]   Barriers to access to medical cannabis for Canadians living with HIV/AIDS [J].
Belle-Isle, L. ;
Hathaway, A. .
AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2007, 19 (04) :500-506
[9]  
Bone M., 2021, ROUTLEDGE HDB POSTPR
[10]   Perceptions of cannabis as a stigmatized medicine: a qualitative descriptive study [J].
Bottorff, Joan L. ;
Bissell, Laura J. L. ;
Balneaves, Lynda G. ;
Oliffe, John L. ;
Capler, N. Rielle ;
Buxton, Jane .
HARM REDUCTION JOURNAL, 2013, 10